ANGPTL3 drugs for Atherosclerotic Cardiovascular Disease
6 tracked ANGPTL3 drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the ANGPTL3 page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
3 Phase 23 Phase 1
Head-to-head evidence: ALN-ANG3 vs EDP167 · ALN-ANG3 vs NNC0491-6075 · ALN-ANG3 vs Solbinsiran · CTX310 vs EDP167 · CTX310 vs NNC0491-6075 · CTX310 vs Solbinsiran